Abstract:e24276 Background: Hepatocellular carcinoma (HCC), the most common hepatic malignancy, is the second leading cause of cancer-related death worldwide. China accounts for more than 50% of new HCC cases and deaths in the world. The genomic profiles of HCC in Chinese patients had not been thoroughly elucidated to facilitate diagnosis and treatment. Methods: FFPE tumor and matched blood samples of 181 Chinese HCC patients, including 152 males (median age of 54) and 29 females (median age of 52), were collected for next-generation sequencing-based 450 genes panel assay. Genomic alterations (including single base substitutions, short and long insertions/deletions, copy number variations, and gene rearrangement in selected genes) and tumor mutational burden were assessed. In addition, the expression of tumor cell PDL1 was also evaluated by FDA-cleared DAKO 22c3 antibody. Results: The most frequently mutated genes in 181 Chinese HCC were TP53 (59.7%), TERT (34.3%), CTNNB1 (21.5%), AXIN1 (12.2%), RB1 (11.0%), STK24 (11.0%), ARID1A (9.9%), CCND1 (7.7%), TSC2 (6.6%) and FGF19 (6.6%). The mutation rates of TERT (p = 0.027) and RB1 (p = 0.016) were significantly higher in patients (pts) with TMB greater than the cohort medium of 7.2 muts/Mb. In addition, loss of function mutation of PBRM1 was found in 2.8% of the pts. About 7% of the patients had TMB value higher than 20 muts/Mb, compared to 1-2% in Western HCC pts, and 31% higher than 10 muts/Mb. Seventy-four patients (median age 54 years; median TMB 6.8 muts/Mb) had tumorous PDL1 expressions assessed by IHC assay. Thirty-six percent of patients were positive of PDL1 (tumor portion score TPS greater than 1%). Only three pts possessed both high TMB and high PDL1 expression (TPS > 50). No correlation was observed between the expression of PDL1 and TMB (r = 0.1). Conclusions: This is the first genomic profiling study of Chinese HCC pts along with TMB and PDL1 expression results. With less actionable gene alterations but more often high TMB and PDL1 expression than their Western counterparts, Chinese HCC pts could potentially benefit more from immune check point inhibitor-based therapies. However, no correlation was observed between the expressions of PDL1 and TMB values.

The Status of P16 Gene in Primary Hepatocellular Carcinoma from a Chinese Population

[A Study on the Inactivation of P16 Genes and the Expression of P16 Protein in Primary Hepatocellular Carcinomas].

[Study of Deletion and Mutation of P16 Gene in Primary Hepatocellular Carcinoma].

The effects of p16 gene methylation on the risk of non-small cell lung cancer

Characterization of Genomic Alterations, Tumor Mutational Burden and PDL1 Expression in 181 Chinese Hepatocellular Carcinomas.

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis.

Effect of P16 Gene on Carcinogenesis of Hepatitis B Virus Related Hepatocellular Carcinoma

The abnormalities of p16 gene expression and the methylation status of p16 gene promotor in gastric cancer

P16 Methylation Was Associated with the Development, Age, Hepatic Viruses Infection of Hepatocellular Carcinoma, and P16 Expression Had a Poor Survival

[P16 and Cyclind1 Protein Expression and P16 Gene Mutation in Primary Human Hepatocellular Carcinoma].

The Genetic Alteration of P16 and CDK4 Genes and Their Relations to HBV Infection in Human Hepatocellular Carcinoma

Genetic Aberration in Primary Hepatocellular Carcinoma: Correlation Between P53 Gene Mutation and Loss-of-hetero- Zygosity on Chromosome 16Q21-Q23 and 9P21-P23

p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA)

Allelic Loss And Gain, But Not Genomic Instability, As The Major Somatic Mutation In Primary Hepatocellular Carcinoma

Hypermethylation of CpG island at p16 gene promoter in gastric carcinomas

The role of p16 gene mutation in human brain glioma tumorigenesis

Relationship Between Expression of P15 and P16 Genes in HCC

Study on Genetic Alterations in Chromosomes 8p and 16q in Primary Hepatocellular Carcinoma

[Mutation Analysis of P16 Gene in Non-Small Cell Lung Carcinomas].

Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.